Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
Institut du Cancer de Montpellier - Val d'Aurelle
Imperial College London
Northwestern University
Northwestern University
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Centre Oscar Lambret
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Duke University
Dana-Farber Cancer Institute
University of Miami
University of Tennessee Graduate School of Medicine
Asan Medical Center